Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression
Seung-Myoung Son(Chungbuk National University), Young Hyeh Ko(Cheju Halla General Hospital), Dongryul Oh(Samsung Medical Center), Sang‐Yun Ha(Samsung Medical Center), Won-Seog Kim(Samsung Medical Center), Hae-Yong Yoo(Samsung (South Korea)), Seok‐Jin Kim(Samsung Medical Center)
Cited by 21
Related Papers
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
|New England Journal of Medicine|2022|342
Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
|Journal of Clinical Oncology|2019|154
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
|The Lancet Oncology|2009|120
Role of 18F-FDG PET/CT in Management of High-Grade Salivary Gland Malignancies
|Journal of Nuclear Medicine|2007|106